发明名称 |
Treatment of acute coronary syndrome with GLP-1 |
摘要 |
The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 molecule. The GLP-1 can be self-administered, and can be administered in one or more doses, as needed, on an intermittent or continuous basis, to optimize metabolism in cardiac tissue and to prevent cardiac damage associated with ischemia.
|
申请公布号 |
US6706689(B2) |
申请公布日期 |
2004.03.16 |
申请号 |
US20010859804 |
申请日期 |
2001.05.18 |
申请人 |
AMYLIN PHARMACEUTICALS, INC. |
发明人 |
COOLIDGE THOMAS R.;EHLERS MARIO |
分类号 |
A61K9/08;A61F2/958;A61K9/20;A61K9/72;A61K31/19;A61K31/7004;A61K33/14;A61K38/12;A61K38/22;A61K38/26;A61K45/00;A61K48/00;A61P9/10;A61P43/00;(IPC1-7):A61K38/22 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|